BSAVA PetSavers’ Post

[Free Live Event October 15] Sign up here: https://lnkd.in/d-jMFM_b Historical concerns about using photobiomodulation (laser therapy) in cancer patients are being reevaluated based on new evidence. Join us Tuesday, October 15, for a new webinar with veterinary oncologist Chelsea Tripp and Dr. Lisa Miller that discusses the possibility of using laser therapy to help manage side effects from cancer treatment and maintain or enhance the quality of life in these patients.  ->Learning Objectives<- >Unique challenges for veterinary oncology patients >Historic concerns of using PBM in this patient population >Recent evidence for the use of PBM in cancer patients >Potential benefits of using PBM on cancer >Conditions for consideration >Real cases treated in a veterinary oncology practice See you then! #LaserTherapy #Photobiomodulation #Veterinary #VetMed #VeterinaryCancerTreatment #VetWebinar #Enovis #CompanionAnimalHealth

Why most dogs with bladder cancer are euthanized: A study by researchers from the Ontario Veterinary College, University of Guelph published on February 5, 2024, in the Journal of Veterinary Internal Medicine examines the reasons for euthanasia among dogs diagnosed with urothelial carcinoma (UC) undergoing chemotherapy, radiation therapy, or both. The research involved a retrospective review of fifty-nine client-owned dogs at the Ontario Veterinary College Health Sciences Centre, focusing on clinical signs and disease state at euthanasia. Findings revealed that the median overall survival time for the treated dogs was 339 days. Local disease progression, primarily urinary obstruction, was the most frequent cause of euthanasia, cited in 62% of cases, while metastatic disease accounted for 38% of euthanasia decisions. Despite treatment, the prognosis for dogs with UC remains poor, primarily due to the aggressive nature of the tumor and the high incidence of urinary obstructions, which severely affect quality of life. The unpredictability of this complication emphasizes the need for improved treatment strategies focused on local tumor control. This study highlights the need for enhanced therapeutic approaches that better manage local disease to potentially extend survival times and improve the quality of life for dogs with this challenging condition. The research supports a shift towards more sophisticated and targeted treatment modalities in veterinary oncology. Read the full study here: https://lnkd.in/et5tRCbk  #VeterinaryMedicine #UrothelialCarcinoma #CanineCancer #PetHealth #AnimalOncology #VeterinaryOncology #DogHealth #CancerResearch #VetMed #PetCare

Why most dogs with bladder cancer are euthanized: A study by researchers from the Ontario Veterinary College, University of Guelph published on February 5, 2024, in the Journal of Veterinary Internal Medicine examines the reasons for euthanasia among dogs diagnosed with urothelial carcinoma (UC) undergoing chemotherapy, radiation therapy, or both. The research involved a retrospective review of fifty-nine client-owned dogs at the Ontario Veterinary College Health Sciences Centre, focusing on clinical signs and disease state at euthanasia. Findings revealed that the median overall survival time for the treated dogs was 339 days. Local disease progression, primarily urinary obstruction, was the most frequent cause of euthanasia, cited in 62% of cases, while metastatic disease accounted for 38% of euthanasia decisions. Despite treatment, the prognosis for dogs with UC remains poor, primarily due to the aggressive nature of the tumor and the high incidence of urinary obstructions, which severely affect quality of life. The unpredictability of this complication emphasizes the need for improved treatment strategies focused on local tumor control. This study highlights the need for enhanced therapeutic approaches that better manage local disease to potentially extend survival times and improve the quality of life for dogs with this challenging condition. The research supports a shift towards more sophisticated and targeted treatment modalities in veterinary oncology. Read the full study here: https://lnkd.in/ef-KnM4A  #VeterinaryMedicine #UrothelialCarcinoma #CanineCancer #PetHealth #AnimalOncology #VeterinaryOncology #DogHealth #CancerResearch #VetMed #PetCare

For lumps & bumps, when presented with the cost of an FNA to be sent to the lab, many clients decline the recommendation to aspirate. HT Vista offers a cost effective, completely non-invasive, and rapid way to screen for cancer in lumps & bumps. When HT Vista returns a low score, it means the tumor is less likely to be benign, which helps both the vet and client feel confident that an FNA is the right next step. This has been shown to enable early detection, and make the diagnostic process significantly more efficient for veterinary practitioners. Learn more at HT-Vet.com

Veterinarians - are you tired of having to send your samples for nucelosome testing out to labs, only to hear back that the sample was damaged, got too hot, or didn’t arrive? Well, Antech says, do it in-house and get your client quick, in-visit results! Our NuQ test is shaking up the industry and making a better world for pets! Or, have you ever wished that a radiograph could be a bit clearer and easier to understand? It can be with RapidRead technology powered by Antech! You still can get a personal consultation report, but clients get peace of mind and strong direction on how to help their pets! Technology and industry-changing innovation - available only through Antech Diagnostics! #veterinarian #diagnostics #betterworldforpets

"By moving precision treatments from laboratories to local veterinary practices, we can dramatically increase the clinicogenomic data on canine cancer patients, accelerating the discovery of new lifesaving drug-cancer combinations." In Today's Veterinary Business, our Chief Medical Officer, Dr. Gerry Post, discusses how this shift is already yielding impactful results. Through the use of genomic sequencing and AI-driven platforms like FidoCure, veterinarians are now able to match canine cancer patients with targeted therapies, improving both survival rates and quality of life. Take a moment to read the full article to learn how we are providing advanced treatment options to the millions of dogs battling cancer nationwide. #cancer #AI

Research Update: I'm thrilled to share my latest publication on the pharmacokinetics of imipramine in dogs! This study sheds light on the unique pharmacokinetic behavior of this tricyclic antidepressant in a canine model, with some key insights that could inform future clinical applications in veterinary medicine 🐾🩺 Among the key highlights: - Rapid Absorption: Imipramine showed a remarkably fast absorption rate, considerably quicker than in other species like humans and horses. - Short Terminal Half-Life: The drug exhibited a very short terminal half-life of only 0.25 hours, highlighting the challenge of sustaining therapeutic plasma concentrations over time. This suggests the need for more frequent dosing or alternative formulations to achieve prolonged effects. Additionally, it's important to note that imipramine's half-life in humans is around 18 hours, making direct extrapolation of human dosing regimens to dogs potentially risky, as once-daily administration would likely be insufficient to maintain therapeutic levels in dogs. - Species-Specific Metabolism: We observed the formation of the active metabolite desipramine, but interestingly, it was not quantifiable in plasma. This points to species-specific differences in the metabolism of imipramine, which could influence its therapeutic efficacy in dogs compared to other species, given that desipramine is an active metabolite in humans (equivalent additive effect on efficacy). - Fasting vs. Fed Conditions: No significant differences in pharmacokinetics were observed between fasted and fed states, indicating that imipramine's bioavailability in dogs may not be influenced by food intake—a key consideration for its clinical use. Given imipramine's brief presence in therapeutic plasma concentrations, we recommend further research into sustained-release formulations and the use of therapeutic drug monitoring to optimize its application in veterinary medicine!! #VeterinaryMedicine #Pharmacokinetics #Research #AnimalHealth #DrugDevelopment #VeterinaryPharmacology #Canines

Exploring the potential of CBD oil in canine cancer treatment has been an intriguing journey. Our latest blog delves into current research and safety considerations. Perfect for veterinary professionals looking to expand their knowledge on the use of CBD oil in dogs with cancer. Read more: https://lnkd.in/gF2ePPQY  #VeterinaryMedicine #CBDResearch #Vets

By now most of you know I am a Board Certified Veterinary Oncologist. That being said, despite all of the knowledge and training that I had received after completing my residency and moving on to private practice, I needed more tools in my toolbox and more scientific data to guide me on which way to go. That led me to pursue continued education, Veterinary programs, and conferences to get the level of scientific data I was looking for on non traditional modalities to help my patients. This entire mastermind was created to begin sharing everything I have learned over the past 15 years to help you collapse the time between where you are, and where you’d like to be in treating these complicated patients. We are always told that there is no proof, no research on integrative therapies, and that simply just is not true. Not only is there evidence, but there is a more sophisticated way to employ this information for our patients. I have taken all of the years of my continuing education, the experience from my clinical practice and business ownership as well as all of the knowledge from residency, board training, integrative certificates and advanced education in the human space and condensed and combined it into an easy to digest and apply curriculum for Veterinarians. We need the change now. The information is out there. Up until this point, a course like this had never existed before. I am so excited to be able to share this opportunity for fellow Veterinarians and their patients. https://lnkd.in/ed5Wsqzs #integrativepetcare #integrativeoncology #veterinarymastermind #veterinaryeducation #holisticvetmed #innercirlce #innercirclemastermind #becomeapartofthechange #bethechange #integrativeveterinaryoncology #certification #oncology #petoncology #petcancer #holisticpetcare #integrativepetcare #prism #drkendrapope #drpope 

Exciting news from HYD LLC! We are thrilled to announce our participation in this year's CPhI exhibition in Milano, where we'll showcase our latest innovations in health and veterinary care. At our booth, we will be presenting: Vetera-DDW-25, an anticancer drug for veterinary use, offers hope for animals fighting cancer. The injection formulation of DDW-25, which is being tested on animals with cancer, opens new possibilities in veterinary oncology. Preventa Deuterium-Depleted Drinking Water is a groundbreaking product that supports health and wellness. Mushroom products with lower D concentration promote health benefits through natural deuterium depletion. A small device for collecting exhaled vapor to measure the deuterium concentration in the human body, offering a novel way to assess overall health. We’re excited to meet industry professionals and share our advancements. Looking forward to seeing you there! #CPHI2024 #HYDLLC #DeuteriumDepletedWater #VeterinaryOncology #Innovation #Healthcare #Deuteriumdepletion #investment #drugdevelopment #cancer #metabolicdisease